SEARCH

SEARCH BY CITATION

References

  • 1
    Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur. Urol. 2006; 49: 798805.
  • 2
    Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics. Tumors of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2004.
  • 3
    Thoenes W, Storkel S, Rumpelt HJ, Moll R. Cytomorphological typing of renal cell carcinoma – a new approach. Eur. Urol. 1990; 18 (Suppl 2): 69.
  • 4
    Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997; 183: 1313.
  • 5
    Jung SJ, Chung JI, Park SH, Ayala AG, Ro JY. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis. Am. J. Surg. Pathol. 2006; 30: 41115.
  • 6
    Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson CN, Neumann RD. Collecting duct carcinoma of the kidney. Hum. Pathol. 1990; 21: 44956.
  • 7
    Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer 1992; 4: 2678.
  • 8
    Koyle MA, Hatch DA, Furness PD III, Lovell MA, Odom LF, Kurzrock EA. Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma. J. Urol. 2001; 166: 14558.
  • 9
    Kuhn E, De Anda J, Manoni S, Netto G, Rosai J. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literature. Am. J. Surg. Pathol. 2006; 30: 137281.
  • 10
    Latif F, Duh FM, Gnarra J et al. von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region. Cancer Res. 1993; 53: 8617.
  • 11
    Lefevre M, Couturier J, Sibony M et al. Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am. J. Surg. Pathol. 2005; 29: 157681.
  • 12
    Lendvay TS, Marshall FF. The tuberous sclerosis complex and its highly variable manifestations. J. Urol. 2003; 169: 163542.
  • 13
    Mancini V, Battaglia M, Ditonno P et al. Current insights in renal cell cancer pathology. Urol Oncol. 2008; 26: 22538.
  • 14
    Martignoni G, Brunelli M, Gobbo S et al. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal. Quant. Cytol. Histol. 2007; 29: 419.
  • 15
    Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am. J. Surg. Pathol. 2007; 31: 157885.
  • 16
    Montironi R, Mazzucchelli R, Lopez-Beltran A et al. Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur. Urol. 2008; 54: 123746.
  • 17
    Montironi R, Mikuz G, Algaba F, Lopez-Beltran A, Hamilton PW, Parkinson C. Epithelial tumours of the adult kidney. Virchows Arch. 1999; 434: 28190.
  • 18
    Montironi R, Scarpelli M, Martignoni G, Cheng L, Lopez-Beltran A. Splitting and lumping adult renal epithelial tumours: is that what the urologists want? Eur. Urol. 2008; 53: 6735; discussion 676–80.
  • 19
    Nagy A, Wilhelm M, Sukosd F, Ljungberg B, Kovacs G. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer 2002; 35: 25660.
  • 20
    Nickerson ML, Warren MB, Toro JR et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell. 2002; 2: 15764.
  • 21
    Paner GP, Srigley JR, Radhakrishnan A et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am. J. Surg. Pathol. 2006; 30: 1319.
  • 22
    Patard JJ, Pouessel D, Bensalah K, Culine S. Targeted therapy in renal cell carcinoma. World J. Urol. 2008; 26: 13540.
  • 23
    Presti JC Jr, Moch H, Reuter VE, Huynh D, Waldman FM. Comparative genomic hybridization for genetic analysis of renal oncocytomas. Genes Chromosomes Cancer 1996; 17: 199204.
  • 24
    Rakozy C, Schmahl GE, Bogner S, Storkel S. Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod. Pathol. 2002; 15: 116271.
  • 25
    Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA. Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer 1987; 59: 51626.
  • 26
    Sanders ME, Mick R, Tomaszewski JE, Barr FG. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am. J. Pathol. 2002; 161: 9971005.
  • 27
    Schmidt L, Duh FM, Chen F et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 1997; 16: 6873.
  • 28
    Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am. J. Surg. Pathol. 2006; 30: 10916.
  • 29
    Speicher MR, Schoell B, du Manoir S et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am. J. Pathol. 1994; 145: 35664.
  • 30
    Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin. Diagn. Pathol. 1998; 15: 5467.
  • 31
    Sterlacci W, Verdorfer I, Gabriel M, Mikuz G. Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies. Virchows Arch. 2008; 452: 915.
  • 32
    Suzigan S, Lopez-Beltran A, Montironi R et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am. J. Clin. Pathol. 2006; 125: 21722.
  • 33
    Thoenes W, Storkel S, Rumpelt HJ, Moll R, Baum HP, Werner S. Chromophobe cell renal carcinoma and its variants – a report on 32 cases. J. Pathol. 1988; 155: 27787.
  • 34
    Tickoo SK, dePeralta-Venturina MN, Harik LR et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 2006; 30: 14153.
  • 35
    Tickoo SK, Reuter VE, Amin MB et al. Renal oncocytosis: a morphologic study of fourteen cases. Am. J. Surg. Pathol. 1999; 23: 1094101.
  • 36
    Tomlinson IP, Alam NA, Rowan AJ et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 2002; 30: 40610.
  • 37
    Toro JR, Wei MH, Glenn GM et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J. Med. Genet. 2008; 45: 32131.
  • 38
    Turbiner J, Amin MB, Humphrey PA et al. Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am. J. Surg. Pathol. 2007; 31: 489500.
  • 39
    Weirich G, Glenn G, Junker K et al. Familial renal oncocytoma: clinicopathological study of 5 families. J. Urol. 1998; 160: 33540.
  • 40
    Went P, Dirnhofer S, Salvisberg T et al. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Am. J. Surg. Pathol. 2005; 29: 838.
  • 41
    Woodward ER. Familial non-syndromic clear cell renal cell carcinoma. Curr. Mol. Med. 2004; 4: 8438.
  • 42
    Yang XJ, Zhou M, Hes O et al. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am. J. Surg. Pathol. 2008; 32: 17787.
  • 43
    Zisman A, Chao DH, Pantuck AJ et al. Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype. J. Urol. 2002; 168: 9505.
  • 44
    Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal. Quant. Cytol. Histol. 2006; 28: 22836.
  • 45
    Adley BP, Smith ND, Nayar R, Yang XJ. Birt-Hogg-Dube syndrome: clinicopathologic findings and genetic alterations. Arch. Pathol. Lab. Med. 2006; 130: 186570.
  • 46
    Adsay NV, Eble JN, Srigley JR, Jones EC, Grignon DJ. Mixed epithelial and stromal tumor of the kidney. Am. J. Surg. Pathol. 2000; 24: 95870.
  • 47
    Akhtar M, Tulbah A, Kardar AH, Ali MA. Sarcomatoid renal cell carcinoma: the chromophobe connection. Am. J. Surg. Pathol. 1997; 21: 118895.
  • 48
    Algaba F, Trias I, Scarpelli M, Boccon-Gibod L, Kirkali Z, Van Poppel H. Handling and pathology reporting of renal tumor specimens. Eur. Urol. 2004; 45: 43743.
  • 49
    Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am. J. Surg. Pathol. 1997; 21: 62135.
  • 50
    Amin MB, Crotty TB, Tickoo SK, Farrow GM. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am. J. Surg. Pathol. 1997; 21: 112.
  • 51
    Argani P. Metanephric neoplasms: the hyperdifferentiated, benign end of the Wilms tumor spectrum? Clin. Lab. Med. 2005; 25: 37992.
  • 52
    Argani P, Antonescu CR, Couturier J et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 2002; 26: 155366.
  • 53
    Argani P, Antonescu CR, Illei PB et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 2001; 159: 17992.
  • 54
    Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin. Lab. Med. 2005; 25: 36378.
  • 55
    Argani P, Lae M, Hutchinson B et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am. J. Surg. Pathol. 2005; 29: 23040.
  • 56
    Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003; 27: 75061.
  • 57
    Argani P, Olgac S, Tickoo SK et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 2007; 31: 114960.
  • 58
    Bonne AC, Bodmer D, Schoenmakers EF, van Ravenswaaij CM, Hoogerbrugge N, van Kessel AG. Chromosome 3 translocations and familial renal cell cancer. Curr. Mol. Med. 2004; 4: 84954.
  • 59
    Bruder E, Passera O, Harms D et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004; 28: 111732.
  • 60
    Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod. Pathol. 2003; 16: 10603.
  • 61
    Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod. Pathol. 2003; 16: 10539.
  • 62
    Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod. Pathol. 2005; 18: 1619.
  • 63
    Brunelli M, Eccher A, Gobbo S et al. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod. Pathol. 2008; 21: 16.
  • 64
    Brunelli M, Gobbo S, Cossu-Rocca P et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod. Pathol. 2007; 20: 3039.
  • 65
    Camparo P, Vasiliu V, Molinie V et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am. J. Surg. Pathol. 2008; 32: 65670.
  • 66
    Chao D, Zisman A, Pantuck AJ et al. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J. Urol. 2002; 167: 714.
  • 67
    Cheville JC, Lohse CM, Zincke H et al. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am. J. Surg. Pathol. 2004; 28: 43541.
  • 68
    Cossu-Rocca P, Eble JN, Delahunt B et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod. Pathol. 2006; 19: 48893.
  • 69
    Cossu-Rocca P, Eble JN, Zhang S et al. Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis. Mod. Pathol. 2008; 21: 498504.
  • 70
    Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod. Pathol. 2006; 19: 7807.
  • 71
    Dal Cin P, Sciot R, Van Poppel H, Balzarini P, Roskams T, Van den Berghe H. Chromosome changes in sarcomatoid renal carcinomas are different from those in renal cell carcinomas. Cancer Genet. Cytogenet. 2002; 134: 3840.
  • 72
    Davis CJ Jr, Barton JH, Sesterhenn IA, Mostofi FK. Metanephric adenoma. Clinicopathological study of fifty patients. Am. J. Surg. Pathol. 1995; 19: 110114.
  • 73
    Davis CJ Jr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am. J. Surg. Pathol. 1995; 19: 111.
  • 74
    de Peralta-Venturina M, Moch H, Amin M et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am. J. Surg. Pathol. 2001; 25: 27584.
  • 75
    Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod. Pathol. 1997; 10: 53744.
  • 76
    Delahunt B, Sika-Paotonu D, Bethwaite PB et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am. J. Surg. Pathol. 2007; 31: 95760.
  • 77
    Drut R, Drut RM, Ortolani C. Metastatic metanephric adenoma with foci of papillary carcinoma in a child: a combined histologic, immunohistochemical, and FISH study. Int. J. Surg. Pathol. 2001; 9: 2417.
  • 78
    Eble JN. Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: newly recognised entities in the renal cell carcinoma family. Pathology 2003; 35: 499504.
  • 79
    Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am. J. Surg. Pathol. 1997; 21: 112330.
  • 80
    Fine SW, Argani P, DeMarzo AM et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am. J. Surg. Pathol. 2006; 30: 155460.
  • 81
    Fuzesi L, Gunawan B, Bergmann F, Tack S, Braun S, Jakse G. Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p. Histopathology 1999; 35: 15761.
  • 82
    O'Reilly K, Tickoo SK, Amin MB et al. Renal cell tumors arising in end stage renal disease. A karyotypic study with fluorescence in situ hybridization. Mod. Pathol. 2005; 18: 156A.
  • 83
    Granter SR, Fletcher JA, Renshaw AA. Cytologic and cytogenetic analysis of metanephric adenoma of the kidney: a report of two cases. Am. J. Clin. Pathol. 1997; 108: 5449.
  • 84
    Grignon DJ, Che M. Clear cell renal cell carcinoma. Clin. Lab. Med. 2005; 25: 30516.
  • 85
    Grignon DJ, Eble JN. Papillary and metanephric adenomas of the kidney. Semin. Diagn. Pathol. 1998; 15: 4153.
  • 86
    Hes O, Brunelli M, Michal M et al. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann. Diagn. Pathol. 2006; 10: 1339.
  • 87
    Ishida Y, Kato K, Kigasawa H, Ohama Y, Ijiri R, Tanaka Y. Synchronous occurrence of pleuropulmonary blastoma and cystic nephroma: possible genetic link in cystic lesions of the lung and the kidney. Med. Pediatr. Oncol. 2000; 35: 857.
  • 88
    Jockle GA, Toker C, Shamsuddin AM. Metastatic renal oncocytic neoplasm with benign histologic appearance. Urology 1987; 30: 7981.
  • 89
    Jones EC, Pins M, Dickersin GR, Young RH. Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases. Am. J. Surg. Pathol. 1995; 19: 61526.
  • 90
    Jones TD, Eble JN, Wang M et al. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin. Cancer Res. 2005; 11: 722633.
  • 91
    Jones TD, Eble JN, Wang M, Maclennan GT, Jain S, Cheng L. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer 2005; 104: 1195203.
  • 92
    Mostofi FK, Davis CJ Jr. Histological Typing of Kidney Tumors. Springer-Verlag, New York, 1998.
  • 93
    Tickoo SK, de Peralta-Venturina MN, Salama M, Wang Y, Moch H, Amin MB. Spectrum of epithelial tumors in end stage renal disease (ESRD): emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Lab. Invest. 2003; 83: 173A.
  • 94
    Gobbo S, Eble JN, Martignoni G et al. Clear-cell papillary renal cell carcinoma: a distinct histopathological and molecular genetic entity. Am. J. Surg. Pathol. 2008; 32: 123945.